Role of matrix metalloproteinases in renal pathophysiologies.
about
Matrix Metalloproteinases in Non-Neoplastic Disorders.Medical Therapy of Fibrostenotic Crohn's DiseaseImbalanced matrix metalloproteinases in cardiovascular complications of end-stage kidney disease: a potential pharmacological targetMatrix metalloproteinases in kidney homeostasis and diseasesMatrix metalloproteinases, atherosclerosis, proteinuria and kidney disease: Linkage-based approachesUrinary collagen fragments are significantly altered in diabetes: a link to pathophysiologyKruppel-like zinc finger protein Glis2 is essential for the maintenance of normal renal functionsMatrix Metalloproteinase Inhibition Mitigates Renovascular Remodeling in Salt-Sensitive Hypertension.The Concise Guide to PHARMACOLOGY 2013/14: enzymes.Quantitative and qualitative urinary cellular patterns correlate with progression of murine glomerulonephritisImproved elucidation of biological processes linked to diabetic nephropathy by single probe-based microarray data analysisNon-invasive quantification of collagen turnover in renal transplant recipientsHuman nephrosclerosis triggers a hypoxia-related glomerulopathyAge-dependent increases in interstitial collagenase and MAP Kinase levels are exacerbated by superoxide dismutase deficienciesHuman cytomegalovirus induces TGF-β1 activation in renal tubular epithelial cells after epithelial-to-mesenchymal transition.Altered glutamyl-aminopeptidase activity and expression in renal neoplasms.Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation.Membrane-type 4 matrix metalloproteinase (MT4-MMP) modulates water homeostasis in mice.Transplantation of endothelial progenitor cells in treating rats with IgA nephropathy.Increased expression of intranuclear matrix metalloproteinase 9 in atrophic renal tubules is associated with renal fibrosis.Medical therapy of stricturing Crohn's disease: what the gut can learn from other organs - a systematic review.Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment.A glimpse of matrix metalloproteinases in diabetic nephropathy.Progression of kidney disease in non-diabetic patients with coronary artery disease: predictive role of circulating matrix metalloproteinase-2, -3, and -9Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice.Bmi-1 plays a critical role in protection from renal tubulointerstitial injury by maintaining redox balance.Inhibition of metalloprotease hyperactivity in cystic cholangiocytes halts the development of polycystic liver diseasesFibrosis and progression of autosomal dominant polycystic kidney disease (ADPKD).Deficient degradation of homotrimeric type I collagen, α1(I)3 glomerulopathy in oim mice.Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosisMatrix Metalloproteinase-2 Knockout and Heterozygote Mice Are Protected from Hydronephrosis and Kidney Fibrosis after Unilateral Ureteral Obstruction.Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: potential role in renal fibrosis.Role of serotonin in the regulation of renal proximal tubular epithelial cells.DNA hypermethylation in hyperhomocysteinemia contributes to abnormal extracellular matrix metabolism in the kidneyAlternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.Urinary matrix metalloproteinase activity in diabetic kidney disease: a potential marker of disease progression.Diabetes-induced renal injury in rats is attenuated by suraminThe effect of biological sealants and adhesive treatments on matrix metalloproteinase expression during renal injury healing.Matrix metalloproteinase 12 modulates high-fat-diet induced glomerular fibrogenesis and inflammation in a mouse model of obesityThe Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate.
P2860
Q26741827-45AB7F57-FE62-4CB3-8481-FAC620953380Q26777724-3BBF1A77-BE21-4E82-B9A7-BAEF6F9A7551Q26864722-3188A972-1CD5-440E-8ACC-6244069CA7C4Q27004621-D225D7B1-4829-4C13-8055-8343AFC6E824Q27025492-08750E18-8F46-44FF-88D5-38046CB0D474Q28475613-1494D84E-2B8D-4539-B963-36BE23EDF032Q28511036-0FC51D8B-0244-4ED3-A2A6-AEA3C179AF91Q30446389-462E3FF7-77E2-4DF5-97DD-0ECB46863EDDQ30486745-59E8CE72-5CAC-4AAC-9960-7D1C46A5F811Q30999305-04701D0E-4666-4D49-99F9-2429E7354EF2Q31171322-26168802-AF64-454F-8CE0-915235560548Q33590296-D8A01D4E-29B6-4B8F-93E2-E366FC55B316Q33597077-8789971F-A1AD-4744-BC40-C373FA661C1CQ33682406-0087C313-F024-4050-A5DF-8D1F09C0B3E3Q33747809-3938B181-499A-4D53-B2B2-FA639D794A19Q33755267-6F59FFE0-20C8-4BFB-A8BA-E665E4254D0CQ33783946-575DBCA9-C34B-4742-AC8E-EADE41FB4991Q33828362-6740555D-8C2D-49B3-BE0C-74814ABE39E5Q33945229-094C87C1-836D-47A6-BD2C-47A2826BBF08Q34461016-7727619F-E734-4426-BAAB-4C9A1B479723Q34504710-4FE88258-09A1-4709-97DE-320D80E2973CQ34505861-E840DE0C-37A5-495E-85DA-37BC15055756Q34796034-040E8DBB-EEA1-4220-9DD0-30DF9F1DEF9BQ34906086-B79E0ADE-A137-4472-85BF-163D1F84476DQ35001863-C4AA01CA-EB2C-49D1-A580-0B6BF57D5E0CQ35093071-98B64023-81AA-4A14-AD35-0EA4926CF448Q35185224-8BA2EDE3-E049-42E2-BD0E-719CE659CF60Q35194509-18753677-5B73-41B3-82BA-36C3117CC802Q35489554-41BAD1F7-E122-4432-A2E2-AD65890B6DCEQ35688448-5CDFEC75-A5F8-4726-B218-2A508E9F2CB5Q35870277-5306F51F-AC25-4D39-8AD3-C270D633E558Q35877447-E3299157-0127-4B34-882A-8A081C2CFCCAQ36045468-FF81CE79-AA2A-4E82-9360-B99016583F3EQ36171329-AD9E768D-C3F2-4E96-B506-19F0A2CE951FQ36192785-D2CADEB7-0945-465B-9BD5-58785FD518DDQ36206158-371533EF-2341-429F-8FB9-E0A0877B2031Q36296876-0CD0536C-9C4C-44BF-AD3C-A44BBC5FFCDFQ36369242-50D68CFA-9692-44B3-83BC-533B41B38FD3Q36516977-2421D859-B53E-4FEE-818B-0CA3230679F8Q36749450-00E852D3-89C5-4160-BB02-9B06F5BAE9FC
P2860
Role of matrix metalloproteinases in renal pathophysiologies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Role of matrix metalloproteinases in renal pathophysiologies.
@ast
Role of matrix metalloproteinases in renal pathophysiologies.
@en
type
label
Role of matrix metalloproteinases in renal pathophysiologies.
@ast
Role of matrix metalloproteinases in renal pathophysiologies.
@en
prefLabel
Role of matrix metalloproteinases in renal pathophysiologies.
@ast
Role of matrix metalloproteinases in renal pathophysiologies.
@en
P2093
P1476
Role of matrix metalloproteinases in renal pathophysiologies.
@en
P2093
P304
P356
10.1152/AJPRENAL.00421.2006
P577
2006-12-26T00:00:00Z